# Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain

> **NCT01906944** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 62 (actual)

## Conditions studied

- Abdominal Pain

## Interventions

- **DRUG:** Bupivacaine 0.25%
- **DRUG:** Triamcinolone

## Key facts

- **NCT ID:** NCT01906944
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2019-08-18
- **Final completion:** 2019-08-18
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906944, "Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01906944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*